Citigroup Inc Seagen Inc. Put Options Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 09, 2023	BUY	$191.51 - $216.16 $50.5 Million - $57 Million	263,500 Added 1029.3%	289,100 $61.3 Million
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $4.8 Million - $5.28 Million	25,600 New	25,600 $4.93 Million
Q4 2022 Feb 09, 2023	SELL	$117.37 - $139.17 $13.1 Million - $15.5 Million	-111,500 Reduced 88.14%	15,000 $1.93 Million
Q3 2022 Nov 10, 2022	BUY	$135.27 - $180.11 $13.5 Million - $17.9 Million	99,500 Added 368.52%	126,500 $17.3 Million
Q1 2022 May 12, 2022	BUY	$119.61 - $157.85 $3.23 Million - $4.26 Million	27,000 New	27,000 $3.89 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.